The effect of the metabolic syndrome on the risk and outcome of coronary artery bypass graft surgery

Cardiovascular Journal of Africa

Volumn 23, Issue 7, 2012, Pages 400-404

  Swart, Marius J ^a   De Jager, Wihan H ^b   Kemp, Johann T ^b   Nel, Paul J ^b   Van Staden, Sarel L ^b   Joubert, Gina ^c  

^a Mediclinic Bloemfontein ^*  (South Africa)

^b UNIVERSITY OF THE FREE STATE   (South Africa)

^c UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

CABG; Metabolic syndrome

Indexed keywords

ADULT; ANALYTICAL RESEARCH; ARTICLE; CARDIOPULMONARY BYPASS; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; SURGICAL MORTALITY; SURGICAL RISK;

CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84866004578     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2012-055     Document Type: Article

References (31)

1. Parsonet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989; 79(suppl I): I-3-I-12.
2. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9-13. (Pubitemid 29336425)
3. Van Straten AHM, Bramer S, Soliman Hamad MA, et al. Effect of body mass index on early and late mortality after coronary artery bypass grafting. Ann Thorac Surg 2010; 89: 30-37.
4. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002; 40: 418-423. (Pubitemid 34833154)
5. Grover FL. The Society of Thoracic Surgeons National Database: Current status and future directions. Ann Thorac Surg 1999; 68: 367-373.
6. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607. (Pubitemid 19004941)
7. Bruce KD, Byrne CD. The metabolic syndrome: common origins of a multifactorial disorder. Postgrad Med J 2009; 85: 614-621.
8. Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the Insulin Resistance Syndrome. Circulation 2000; 102: 42-47. (Pubitemid 30430551)
9. Santos A-C, Lopes C, Guimarães JT, Barros H. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Intl J Obesity 2005; 29: 1452-1456. (Pubitemid 41622224)
10. Echahidi N, Pibarot P, Després J-P, et al. Metabolic syndrome increases operative mortality in patients undergoing CABG. J Am Coll Cardiol 2007; 50: 843-851. (Pubitemid 47268739)
11. Shah B, Kumar N, Garg P, et al. Metabolic syndrome does not impact survival in patients treated for coronary artery disease. Coron Artery Dis 2008; 19: 71-77. (Pubitemid 351317369)
12. Domanski M. The metabolic syndrome. Clinical research: Atherosclerotic risk factors: Editorial comment J Am Coll Cardiol 2004; 43: 1396-1398.
13. Cheng TO. Metabolic syndrome in China. Circulation 2004; 109: e180.
14. Mollentze WF. Epidemiological aspects in South Africa. S Afr J Diabetes Vasc Dis 2004; 1: 55-56.
15. Zimmet P, Alberti G, Shaw J. A new IDF worldwide definition of the metabolic syndrome: The rationale and the results. Diabetes Voice 2005; 50: 31-33.
16. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (ATPIII). J Am Med Assoc 2001; 285: 2486-2497.
17. Jones RH, Hannan EL, KE Hammermeister, et al. Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. J Am Coll Cardiol 1996; 28: 1478-1487. (Pubitemid 26391853)
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999: 130: 461-470. (Pubitemid 29135798)
19. Shoyer ALW, Coombs LP, Peterson ED, et al. The Society of Thoracic Surgeons: 30 day operative mortality and morbidity risk models. Ann Thorac Surg 2003; 75: 1856-1865. (Pubitemid 36677229)
20. McNeill AM, Rosamond WD, Girmin CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005; 28: 385-390. (Pubitemid 40170944)
21. Malik S, Wong ND, Franklin SS, et al. Impact of metabolic syndrome on mortality from coronary heart disease, cardiovascular disease and all causes in United States adults. Circulation 2004; 110: 1245-1250. (Pubitemid 39202340)
22. Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the Metabolic Syndrome: A joint interim statement of the Internatinal Diabetes Federation Task Force on epidemiology and prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; Internatiol Atherosclerosis Society; and International Association for the study of Obesity. Circulatiom 2009; 120: 1640-1645.
23. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk. Arch Intern Med 2002; 162: 2074-2079.
24. Franco OH, Massaro JM, Civil J, Cobain MR, O'Malley B, D'Agostino RB. Trajectories of entering the metabolic syndrome: The Framingham Heart Study. Circulation 2009; 120: 1943-1950.
25. Tekumit H, Cenal AR, Polat A, Uzun K, Tataroglu C, Akinci E. Diagnostic value of hemoglobin A1c and fasting plasma glucose in coronary artery bypass grafting patients with undiagnosed diabetes mellitus. Ann Thorac Surg 2010; 89: 1482-1489.
26. Ranjith N, Pegoraro RJ, Naidoo DP, Esterhuizen TM. Metabolic syndrome in young Asian Indian patients with myocardial infartion. Cardiovasc J Afr 2007; 18: 228-233. (Pubitemid 351716219)
27. Engel AM, McDonough S, Smith JM. Does an obese body mass index affect hospital outcomes after coronary artery bypass graft surgery? Ann Thorac Surg 2009; 88: 1793-1800.
28. Anand SS, Qilong Y, Gerstein H, et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003; 108: 420-425. (Pubitemid 36935534)
29. Kajimoto K, Miyauchi K, Kasai T, et al. Metabolic syndrome is an independent risk factor for stroke and acute renal failure after coronary artery bypass grafting. J Thorac and Cardiovasc Surg 2009; 137: 658-663.
30. Brackbill ML, Sytsma CS, Sykes K. Perioperative outcomes of coronary artery bypass grafting: Effects of metabolic syndrome and patient's sex. Am J Crit Care 2009; 18: 468-473.
31. Simmons RK, Alberti KGMM, Gale EAM, et al. The metabolic syndrome: Useful concept or clinical tool? Diabetologia 2010; 53: 600-605.